Journal profile
IBJ Clinical Pharmacology
ISSN 2530-4984 · Iberoamerican Journals · Spain
IBJ Clinical Pharmacology: fully open access; APC about USD 215; review about 2 weeks (community reports).
Scope
Aims, scope and focus
IBJ Clinical Pharmacology is published by Iberoamerican Journals. By OpenAlex counts of its recent articles, its largest topics are Drug-Induced Adverse Reactions, Pharmaceutical studies and practices and Autoimmune Bullous Skin Diseases, together about 42.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug-Induced Adverse ReactionsMedicine18.3%
- Pharmaceutical studies and practicesMedicine14.1%
- Autoimmune Bullous Skin DiseasesMedicine9.9%
- Urticaria and Related ConditionsMedicine7%
- Health and Medical EducationHealth Professions4.2%
- Eosinophilic Disorders and SyndromesMedicine4.2%
- Sympathectomy and Hyperhidrosis TreatmentsMedicine4.2%
- Pharmaceutical Practices and Patient OutcomesMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 2OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 59 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2022 | 9 | 9 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 2 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | EUR 200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Iberoamerican Journals
- Country or region
- Spain
- Language
- English, Spanish, Portuguese
- ISSN
- 2530-4984
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about IBJ Clinical Pharmacology
How long does peer review take at IBJ Clinical Pharmacology?
Authors report an average review time of about 2 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is IBJ Clinical Pharmacology open access, and what is the APC?
IBJ Clinical Pharmacology is a fully open-access journal. APC about USD 215.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .